At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Accidents and Their Circumstances With Oral Anticoagulants. The CACAO Study
In Brief
An observational study evaluating Follow up for Cardiovascular Complications and 2 related conditions. Completed, enrolled 4,162 participants across 33 sites.
Detailed Summary
Differences in efficacy and safety between new oral anticoagulants (NOAC) and vitamin K antagonist (VKA) in real practice remain uncertain. The few existing ambulatory studies did not answer all NOAC specific issues, such as prescription habits and motives, patients characteristics, biological monitoring, as well as the occurrence of major and minor thromboembolic events, especially in France where warfarin is less frequently prescribed. Therefore, in order to describe clinical and follow up characteristics of patients receiving oral anticoagulants, the investigators will set up a national prospective cohort to compare the occurrence of thromboembolic events between VKA and NOAC in primary care.
Study Details
Timeline
Interventions
each three months during one year of follow up, general practioners will entered health data in database (hemorrhagic events, changes of medication, biological data...)